• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Report: Media-journal collaboration often leads to misinformation

Report: Media-journal collaboration often leads to misinformation

December 15, 2016
CenterWatch Staff

When flawed clinical research is reported in the media with hype and sensationalism, it has the potential to have a devastating effect on patients, physicians, the scientific community and eventually society as a whole.

In a review article in the journal EMBO Reports, the authors question how controversial and weak studies are publicized by the media and often coupled with a narrative that is either false or with little scientific basis. The blame for misleading the public, they believe, should be shouldered equally by journalists, scientists, journal editors and research institutions.

As an example, the authors describe the changes in medical attitudes and practices regarding the use of hormone replacement therapy (HRT) in peri- and post-menopausal women following intense coverage of the Women's Health Initiative study. In 2002, the media reported that this large study had been prematurely halted after it showed greater risks of stroke, death and invasive breast cancer for women who took estrogen and progesterone compared with those who received placebo. Physicians called for immediate curtailment of HRT use in women and prescriptions fell by more than 80% and remained at that level for years. Today, healthcare experts still routinely reference this study as demonstrating the dangers of HRT despite the fact that a 2013 follow-up study reported no significant difference between HRT and placebo for mortality or a long list of other adverse events.

"We believe that the collaboration between media and scientific journals in communicating advances in science and medicine to the public may result in misinformation and distortion. Unfortunately, this collaboration often exaggerates and allows bad science to be disseminated and shared. Media is often drawn to these controversial studies and they promote them with a narrative that is difficult to change even if it is wrong," explained lead author Abdulmaged M. Traish, Ph.D., professor of biochemistry and urology at Boston University School of Medicine.

Traish and his colleagues believe a number of strategies could help prevent medical professionals and the general public from accepting distorted study results and their coverage in the media, including recognizing the collaboration between medical journals; being wary of pronouncements from individuals who are unlikely to have clinical experience with a drug or treatment and recognizing the limitations of any one study since as many as 70% of the most highly cited studies eventually prove to be unreproducible.

Traish believes this critical analysis of how the media and medical journals promote questionable studies is of critical importance to the public, academics, policy makers and research institutions. "This is an issue that needs to be discussed, debated and taught to our medical students to be prepared to enter the real world of medicine and its complexities."

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing